Gastric Cancer Foundation Gastric Cancer Foundation | Hope in Research

GCF-AGA Grant Recipient El-Zaatari Charts Progress on Three Research Efforts

Sep 10 2019

Ever since Mohamad El-Zaatari, Ph.D., research assistant professor at the University of Michigan, received the first GCF-American Gastroenterology Association grant...
Read More
Helicobacter pylori infection, chronic atrophic gastritis and riskof stomach and esophagus cancer: Results from the prospec tivepopulation-based ESTHER cohort study

Sep 06 2019

A cohort study involving nearly 10,000 patients found that infection with H. Pylori in the presence of chronic atrophic gastritis...
Read More
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study

Sep 04 2019

In a trial involving 949 patients with 40 tumor types, including gastric cancer, a blood test from Guardant Health was...
Read More
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication

Aug 27 2019

A new study finds that patients with type 2 diabetes who are treated for H. Pylori infection face an increased...
Read More
New Combination Shows Early Promise in Gastric Cancer

Aug 26 2019

A combo of the immuno-oncology drug Keytruda with the VEGFR-2 inhibitor Cyramza was well tolerated by gastric cancer patients in...
Read More
Vanderbilt team shows how stomach bug can trigger cancer

Aug 20 2019

Researchers at Vanderbilt and the University of Michigan uncovered the mechanisms by which H. Pylori injects a cancer-promoting protein into...
Read More
Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination With D2 Gastrectomy

Aug 19 2019

A recent study found that the XELOX chemo regimen given before and after surgery in patients with locally advanced gastric...
Read More
Perioperative FOLFIRINOX for Gastroesophageal Adenocarcinoma

Aug 13 2019

In a trial, the chemotherapy regimen FOLFIRINOX produced response rates on par with FLOT and may be easier to tolerate,...
Read More
Chemo-Refractory Gastric Cancer Treated With Toripalimab

Aug 12 2019

In a trial of the investigational PD-1 antibody toripalimab, gastric cancer patients with a high tumor mutational burden showed superior...
Read More
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

Aug 07 2019

Adding Tykerb to chemotherapy in HER-2 positive gastric cancer patients was proven safe in a phase 2 trial
Gastric cancer rates higher among patients treated for H. pylori

Aug 06 2019

A recent study showed that people who are treated for H. Pylori infections experience higher gastric cancer rates, but it’s...
Read More
Greater Awareness Needed of Stomach Cancer Risk in Under-40s, Especially in Latin America

Aug 03 2019

A study from Mexico found that one in seven people diagnosed with gastric cancer were under 40 and over half...
Read More
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

Aug 01 2019

Researchers at MD Anderson used DNA and RNA sequencing to identify gene mutations linked with aggressive peritoneal metastases in gastric...
Read More
The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study

Jul 31 2019

Some have suggested poor oral health raises the risk of gastric cancer, but a new analysis of more than 475,000...
Read More
Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection

Jul 30 2019

New clinical trials will examine the use of the drug DFMO for preventing gastric cancer in people with the H....
Read More
Role of vitamin D supplementation for primary prevention of cancer: Meta-analysis of randomized controlled trials.

Jul 29 2019

A new analysis of multiple studies, presented at ASCO, suggests that Vitamin D may help decrease cancer-related mortality but that...
Read More
For stomach cancer, aerosol chemotherapy offers breath of hope

Jul 25 2019

Scientists in France are developing an aerosol chemotherapy for gastric cancer that may help patients avoid side effects like stomach...
Read More
Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer

Jul 24 2019

In a recent study, patients with gastrointestinal cancers who had immune-related adverse events while taking checkpoint inhibitors had progression-free survival...
Read More
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma

Jul 22 2019

A recent study in patients with metastatic gastric cancer showed that adding docetaxel to a modified FOLFOX7 chemo regimen produced...
Read More
H. pylori eradication helps reduce risk of de novo gastric cancer

Jul 19 2019

Korean scientists found that eradicating H. Pylori reduces the risk of new gastric cancer diagnoses.

SATURDAY, NOVEMBER 16

ADVANCE RESEARCH BY
JOINING THE GASTRIC
CANCER REGISTRY

FIND CLINICAL TRIALS
USING OUR FREE
TRIAL NAVIGATOR

JOIN OUR ONLINE
COMMUNITY OF PATIENTS
AND FAMILY MEMBERS

Support Research for a Cure

Nutrition Videos

Alternate Grain Pasta

The Power of Probiotics

Roasted Rainbow Carrots

Zesty Cranberries

Fall Pumpkins

Kaiserschmarrn

Breaking Down Digestion

A Hot New Take on Chili

What's New

GCF-AGA Grant Recipient El-Zaatari Charts Progress on Three Research Efforts

Helicobacter pylori infection, chronic atrophic gastritis and riskof stomach and esophagus cancer: Results from the prospec tivepopulation-based ESTHER cohort study

Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study

T2DM Increases Gastric Cancer Risk After H. Pylori Eradication

New Combination Shows Early Promise in Gastric Cancer

Vanderbilt team shows how stomach bug can trigger cancer

Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination With D2 Gastrectomy

Perioperative FOLFIRINOX for Gastroesophageal Adenocarcinoma

Chemo-Refractory Gastric Cancer Treated With Toripalimab

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

Gastric cancer rates higher among patients treated for H. pylori

Greater Awareness Needed of Stomach Cancer Risk in Under-40s, Especially in Latin America

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study

Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection

Role of vitamin D supplementation for primary prevention of cancer: Meta-analysis of randomized controlled trials.

For stomach cancer, aerosol chemotherapy offers breath of hope

Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma

H. pylori eradication helps reduce risk of de novo gastric cancer

Monthly Newsletter

Making Strategic Investments Toward a Cure

SATURDAY, NOVEMBER 16

ADVANCE RESEARCH BY JOINING THE GASTRIC CANCER REGISTRY

FIND CLINICAL TRIALS USING OUR FREE TRIAL NAVIGATOR

JOIN OUR ONLINE COMMUNITY OF PATIENTS AND FAMILY MEMBERS

Support Research for a Cure

Nutrition Videos

What's New

Monthly Newsletter

Making Strategic Investments Toward a Cure

ADVANCE RESEARCH BY
JOINING THE GASTRIC
CANCER REGISTRY

FIND CLINICAL TRIALS
USING OUR FREE
TRIAL NAVIGATOR

JOIN OUR ONLINE
COMMUNITY OF PATIENTS
AND FAMILY MEMBERS